poisar

Stocks · News reference

UBS Adjusts Kenvue Price Target

Fiscal.ai

UBS has updated its price target for Kenvue Inc. while maintaining a Neutral rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Kenvue Inc. (KVUE)

    Filed: 2026-11-04 AccNo: 0001104659-26-122777 Size: 199 KB Item 3.03: Material Modifications to Rights of Security Holders Item 9.01: Financial Statements and Exhibits

  2. The Motley FoolEric Volkman

    Kimberly-Clark Acquires Kenvue. Here’s What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.

    Kimberly-Clark completed its $48.7 billion acquisition of Kenvue on Monday, creating a consumer goods and healthcare powerhouse with 10 billion-dollar brands. The deal was funded through senior notes and the sale of a 51% stake in its paper business to Suzano. The company expects $2.1 billion in annual synergies within three years and aims to maintain its 54-year Dividend King status through incremental raises, though share buybacks have been suspended.